Connect with us

Latest News

Infosys Invests in 4baseCare to Boost Healthcare Tech Offerings!

Published

on

Infosys Invests in 4baseCare to Boost Healthcare Tech Offerings!

Infosys, a global leader in next-generation digital services and consulting, has announced a strategic investment of INR 8.3 crore (approximately $1 million) in 4baseCare, a promising healthcare deep-tech firm specializing in precision oncology solutions. This investment underscores Infosys’ commitment to leveraging cutting-edge technologies to address critical healthcare challenges.

About 4baseCare

Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare focuses on utilizing advanced genomics and clinical data to personalize cancer treatment. The firm employs AI and analytics to improve cancer diagnosis, treatment, and drug discovery. Their unique approach includes the development of comprehensive genomic panels that enable oncologists to select optimal targeted therapies for patients.

Precision Oncology Solutions

4baseCare’s precision oncology solutions are designed to:

  • Enhance Cancer Diagnosis: By integrating diverse genomic data, the platform allows for more accurate identification of cancer types and stages.
  • Personalize Treatment Plans: Utilizing AI-driven insights, the startup aims to tailor treatment strategies based on individual patient profiles.
  • Accelerate Drug Discovery: The data-driven approach helps streamline the development of new cancer therapies.

Strategic Alignment with Infosys

Infosys’ investment in 4baseCare aligns with its broader strategy to foster innovation and drive digital transformation within the healthcare industry. By partnering with 4baseCare, Infosys aims to enhance its offerings and provide advanced solutions to its clients in the healthcare and life sciences sectors.

Expected Benefits of the Investment

The investment will enable Infosys to tap into 4baseCare’s expertise in precision oncology, allowing it to:

  • Develop innovative healthcare solutions that can improve patient outcomes.
  • Leverage advanced analytics to reduce healthcare costs through more effective treatments.
  • Enhance its portfolio of services aimed at healthcare providers and institutions.

Future Prospects

This strategic move comes at a time when the Indian healthtech startup ecosystem is gaining momentum. Despite facing challenges in fundraising—having raised only $7 billion across 886 deals from 2014 to mid-2024—the sector is witnessing increased interest from investors seeking innovative solutions to pressing healthcare issues.

In recent months, 4baseCare has also made headlines by raising $6 million in its Series A funding round led by Yali Capital, demonstrating strong investor confidence in its potential.

Conclusion

Infosys’ investment in 4baseCare represents a significant step toward enhancing its capabilities in the healthcare sector, particularly in precision oncology. By combining Infosys’ technological prowess with 4baseCare’s innovative solutions, this partnership is poised to make a meaningful impact on cancer treatment and patient care. As both companies work together to advance healthcare technology, they are likely to contribute significantly to improving health outcomes and driving efficiencies within the industry.

Continue Reading
Advertisement
1 Comment

1 Comment

  1. droversointeru

    April 12, 2025 at 8:58 pm

    Nice read, I just passed this onto a friend who was doing a little research on that. And he just bought me lunch as I found it for him smile Thus let me rephrase that: Thank you for lunch!

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Apple’s iOS 18.7 vs iOS 26: Which Update Should You Choose for Your iPhone in 2025?

Published

on

StartupStories iOS 26

Apple’s recent iOS 18.7 rollout provides a secure alternative to the visually revamped iOS 26, empowering iPhone users to choose between system stability and next-generation features. While iOS 18.7 focuses on important security updates and bug fixes, it maintains the familiar iOS experience for users of older devices like iPhone XS, XS Max, XR, and SE models up to the 16e. The update is lightweight—about one-fifteenth the size of iOS 26—which means quicker downloads and less storage consumption. It’s designed for reliability and fast installation, making it ideal for users who prioritize a stable and secure operating system over design changes.

In contrast, iOS 26 introduces Apple’s ambitious “Liquid Glass” interface with a transparent look across apps, enhanced widget and lock screen customization, smarter Siri, and improved camera controls. These innovations, however, come with a larger update size and compatibility exclusive to newer iPhones beginning from the iPhone 11 series. While early adopters can enjoy the futuristic interface and AI-powered upgrades, major OS launches may present initial bugs or app compatibility issues that cautious users typically wish to avoid.

Choosing between iOS 18.7 and iOS 26 depends on each user’s priorities—those seeking guaranteed stability and fast security fixes should consider sticking with iOS 18.7, while users excited about premium features and visual changes should migrate to iOS 26 if their device supports it. Both updates are available through Software Update settings, and Apple will support iOS 18.7 for only a limited duration, eventually encouraging all users to transition to the latest platform. This dual update strategy ensures every iPhone user can safely update their device for a seamless and secure experience in 2025.

Continue Reading

Latest News

Deep-Tech Startup EndureAir Raises INR 25 Crore from IAN Alpha Fund to Boost Drone Innovation

Published

on

StartupStories

EndureAir, a deep-tech drone startup specializing in UAV (Unmanned Aerial Vehicles) and aerial robotics solutions, has successfully raised INR 25 crore in a funding round led by IAN Alpha Fund, with participation from IAN Angel Fund. The fresh capital infusion will enable EndureAir to enhance its advanced drone technologies for defense applications, broaden its reach in enterprise markets, and accelerate the development of next-generation high-altitude logistics and aerial robotics platforms.

Founded in 2018 by Dr. Abhishek, a professor of Aerospace Engineering at IIT Kanpur, along with his former students Rama Krishna and Chirag Jain, EndureAir stands out in India’s indigenous UAV sector by developing both hardware and software in-house. Backed by over 15 years of rotorcraft research and holding eight patents in flight dynamics and autonomous systems, the company has rapidly established itself as a pioneer in the deep-tech drone ecosystem.

EndureAir’s flagship drone platforms, including the Sabal heavy-lift UAV family inducted by the Indian Army’s Eastern Command and the Vibhram drone supporting Telangana’s Medicine from the Sky program, are deployed in critical operations. The startup also collaborates with Bharat Electronics Limited for co-developing high-altitude drones and works with Bhutan’s Druk Holding & Investments on remote logistics missions. With this funding, EndureAir aims to position India as a global leader in UAV innovation, advancing resilient domestic drone systems for defense and enterprise applications.

Continue Reading

Latest News

Venture Catalysts Raises Rs 150 Crore to Boost Multi-Stage VC Platform and AI Capabilities

Published

on

StartupStories

Venture Catalysts, a leading Mumbai-based venture capital platform, has secured Rs 150 crore (around $18 million) through a strategic mix of primary and secondary transactions. This fresh round of funding resulted in a company valuation of approximately $200 million and drew participation from high-profile investors such as Ashish Kacholia, the Shah Rukh Khan family office, Aishwarya Rai, as well as several established capital market veterans and renowned business houses. The move not only demonstrates strong investor confidence but also positions Venture Catalysts at the forefront of India’s rapidly evolving startup landscape.

The infusion of capital is earmarked to accelerate key initiatives, including expanding Venture Catalysts’ leadership team, launching new investment funds, and exploring advanced technology solutions with an emphasis on AI-enabled due diligence and reporting tools. Additionally, the firm aims to strengthen its footprint across major Indian startup hubs and grow its suite of Category II alternative investment funds, harnessing this growth to support a new wave of promising startups and founders within the ecosystem.

Since its inception in 2016, Venture Catalysts has evolved from an angel network to a multi-fund powerhouse, managing over $500 million in assets and deploying nearly $200 million across more than 400 startups, including industry leaders like BharatPe, Renee Cosmetics, and InsuranceDekho. This latest funding round reinforces Venture Catalysts’ pivotal role in nurturing and scaling some of India’s most innovative startups, catalyzing growth throughout the country’s thriving entrepreneurial sector.

Continue Reading
Advertisement

Recent Posts

Advertisement